Andreas Gerber‐Grote

663 total citations
26 papers, 403 citations indexed

About

Andreas Gerber‐Grote is a scholar working on General Health Professions, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Andreas Gerber‐Grote has authored 26 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in General Health Professions, 13 papers in Economics and Econometrics and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Andreas Gerber‐Grote's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Pharmaceutical Economics and Policy (6 papers) and Health and Medical Studies (5 papers). Andreas Gerber‐Grote is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Pharmaceutical Economics and Policy (6 papers) and Health and Medical Studies (5 papers). Andreas Gerber‐Grote collaborates with scholars based in Germany, Switzerland and United Kingdom. Andreas Gerber‐Grote's co-authors include Emelie Heintz, Renata Slabe‐Erker, Salah Ghabri, Sarah Mostardt, Sabine Schickendańtz, Thomas Davidson, Petra Schiller, Uwe Siebert, Dieter Pöhlau and F F Hamers and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Epidemiology and The Journal of Pediatrics.

In The Last Decade

Andreas Gerber‐Grote

25 papers receiving 399 citations

Peers

Andreas Gerber‐Grote
Jessica E. Galarraga United States
Ilene Katz Jewell United States
J Mould-Quevedo United States
Matthew M Coates United States
Ray S. Davis United States
Jessica E. Galarraga United States
Andreas Gerber‐Grote
Citations per year, relative to Andreas Gerber‐Grote Andreas Gerber‐Grote (= 1×) peers Jessica E. Galarraga

Countries citing papers authored by Andreas Gerber‐Grote

Since Specialization
Citations

This map shows the geographic impact of Andreas Gerber‐Grote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Gerber‐Grote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Gerber‐Grote more than expected).

Fields of papers citing papers by Andreas Gerber‐Grote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Gerber‐Grote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Gerber‐Grote. The network helps show where Andreas Gerber‐Grote may publish in the future.

Co-authorship network of co-authors of Andreas Gerber‐Grote

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Gerber‐Grote. A scholar is included among the top collaborators of Andreas Gerber‐Grote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Gerber‐Grote. Andreas Gerber‐Grote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bochud, Murielle, Margaret Chan, Arnaud Chioléro, et al.. (2024). A New Model for Ranking Schools of Public Health: The Public Health Academic Ranking. International Journal of Public Health. 69. 1606684–1606684. 1 indexed citations
2.
Meidert, Ursula, et al.. (2023). Unconscious Bias among Health Professionals: A Scoping Review. International Journal of Environmental Research and Public Health. 20(16). 6569–6569. 20 indexed citations
4.
Huber, Marion, Claudia M. Witt, Andreas Gerber‐Grote, et al.. (2020). Kompetenzen zur interprofessionellen Zusammenarbeit und geeignete Unterrichtsformate. Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences). 2 indexed citations
6.
Danner, Marion, Frank Sandmann, Gaby Sroczynski, et al.. (2018). Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants. MDM Policy & Practice. 3(1). 3441400435–3441400435. 1 indexed citations
7.
Sandmann, Frank, Sarah Mostardt, Stefan K. Lhachimi, & Andreas Gerber‐Grote. (2018). The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?. Expert Review of Pharmacoeconomics & Outcomes Research. 18(5). 475–486. 10 indexed citations
8.
Ehrich, J. H. H., et al.. (2016). The Child Health Care System of Germany. The Journal of Pediatrics. 177. S71–S86. 17 indexed citations
9.
Waffenschmidt, Siw, et al.. (2016). No suitable precise or optimized epidemiologic search filters were available for bibliographic databases. Journal of Clinical Epidemiology. 82. 112–118. 9 indexed citations
10.
Mühlbacher, Axel, John F. P. Bridges, Susanne Bethge, et al.. (2016). Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment. The European Journal of Health Economics. 18(2). 155–165. 46 indexed citations
11.
Franken, M, Emelie Heintz, Andreas Gerber‐Grote, & James Raftery. (2016). Health Economics as Rhetoric: The Limited Impact of Health Economics on Funding Decisions in Four European Countries. Value in Health. 19(8). 951–956. 10 indexed citations
12.
Schickendańtz, Sabine, et al.. (2016). Study of the effectiveness of hippotherapy on the symptoms of multiple sclerosis – Outline of a randomised controlled multicentre study (MS-HIPPO). Contemporary Clinical Trials Communications. 3. 6–11. 11 indexed citations
13.
Waffenschmidt, Siw, et al.. (2016). Health Economic Evaluations of Sofosbuvir for Treatment of Chronic Hepatitis C: a Systematic Review. Applied Health Economics and Health Policy. 14(5). 527–543. 12 indexed citations
14.
Ramos, Isaac Corro, Stefan K. Lhachimi, Andreas Gerber‐Grote, & Maiwenn Al. (2016). Cost Recommendation under Uncertainty in IQWiG’s Efficiency Frontier Framework. Medical Decision Making. 37(2). 162–172. 2 indexed citations
15.
Ultsch, B., Oliver Damm, Philippe Beutels, et al.. (2015). Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics. 34(3). 227–244. 95 indexed citations
16.
Müller, Dirk, Andreas Gerber‐Grote, Björn Stollenwerk, et al.. (2015). Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework. Expert Review of Pharmacoeconomics & Outcomes Research. 16(5). 619–627. 1 indexed citations
17.
Heintz, Emelie, Andreas Gerber‐Grote, Salah Ghabri, et al.. (2015). Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries. PharmacoEconomics. 34(1). 59–76. 62 indexed citations
18.
Gerber‐Grote, Andreas & Jürgen Windeler. (2014). Welchen Beitrag leisten Kosten-Nutzen-Bewertungen bei Entscheidungen im Gesundheitswesen: Erfahrungen aus 7 ausgewählten Ländern. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 108(7). 355–357. 2 indexed citations
19.
Gerber‐Grote, Andreas, Frank Sandmann, Min Zhou, et al.. (2014). Decision making in Germany: Is health economic evaluation as a supporting tool a sleeping beauty?. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 108(7). 390–396. 14 indexed citations
20.
Mostardt, Sarah, et al.. (2014). Standard Costs for Health Economic Evaluations: An International Comparison. Value in Health. 17(7). A427–A427. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026